ELHT(SH:600133) Shang Hai Zheng Quan Bao·2025-09-10 19:15Core Viewpoint - Wuhan Donghu Gaoxin Group Co., Ltd. has provided a guarantee for its wholly-owned subsidiary, Wuhan Donghu Gaoxin Pharmaceutical Investment Co., Ltd., for a loan of RMB 600 million from Agricultural Bank of China [2][5] Summary by Sections Guarantee Details - The guarantee amount is RMB 600 million, and the total amount guaranteed for Donghu Pharmaceutical Investment is also RMB 600 million as of the announcement date [3][4] - There is no counter-guarantee involved in this transaction [4] Financial Context - As of September 10, 2025, the company has provided actual guarantees totaling RMB 1.267 billion for its wholly-owned and controlling subsidiaries, and RMB 10.38 million for its affiliated companies [4][15] - The total amount of external guarantees provided by the company and its controlling subsidiaries is RMB 6.703 billion, which accounts for 75.66% of the audited equity attributable to the parent company for the most recent fiscal year [15] Internal Decision-Making Process - The company's board of directors approved the annual guarantee plan for 2025 on April 25, 2025, allowing for a total guarantee amount not exceeding RMB 6.125 billion for its wholly-owned and controlling subsidiaries [6][14] - The shareholders' meeting on June 5, 2025, ratified the 2025 annual guarantee plan [8] Necessity and Reasonableness of the Guarantee - The guarantee is intended to alleviate financial pressure for project construction and meet operational needs [13] - The guarantee does not constitute a related party transaction and will not harm the interests of the company and its shareholders [5][13] Board of Directors' Opinion - The board believes that the subsidiaries have the ability to repay the loans and that the guarantee will not harm the company's interests [14][15]